Opérations des initiés

EDGAR

Natera, Inc.

Opérations déclarées par les administrateurs, dirigeants et détenteurs de plus de 10 % sur les formulaires 3, 4 et 5 de la SEC, lues dans le XML de chaque dépôt. Les codes et leur libellé sont ceux de la SEC.

Le formulaire 4 doit être déposé dans les deux jours ouvrables suivant l’opération ; les plus récentes peuvent donc ne pas encore être déposées.

Période : opérations datées du 17 nov. 2025 ou après.

Achats sur le marché (code P)
0 opérations, — actions
Ventes sur le marché (code S)
546 opérations, 1 451 822 actions
Somme actions × prix par action : 365 591 600,4009

Les totaux additionnent les opérations déposées listées ; ils comptent ce qui a été déclaré et ne mesurent aucune direction.

Affichage de 1 à 50 sur 653

Opérations des initiés, les plus récentes d’abord, telles que déposées sur les formulaires 3, 4 et 5 de la SEC
DateDéclarantCodeAcquis ou cédéActionsPrix par action, tel que déposéValeur (calculée)Actions détenues aprèsDirecte ou indirecteCase de la règle 10b5-1NotesSource
23 juin 2029 Déposé le 25 juin 2020Brophy Michael Burkes Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Titre dérivé: Restricted Stock Units — sous-jacent Common Stock (12 500)
Cédé (D)12 5000—37 500Directe (D) Absent de cette version du formulaire
F2, F7
  • F2 Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  • F7 On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. On June 23, 2020, the criteria was satisfied for the vesting of RSUs covering 12,500 shares of common stock.
Ouvrir le dépôt 0001179110-20-007780 Lu dans le XML du dépôt Contester cette ligne
8 juin 2029 Déposé le 10 juin 2020Brophy Michael Burkes Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Titre dérivé: Restricted Stock Units — sous-jacent Common Stock (25 000)
Cédé (D)25 0000—50 000Directe (D) Absent de cette version du formulaire
F2, F6
  • F2 Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  • F6 On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. On June 8, 2020, the criteria was satisfied for the vesting of RSUs covering 25,000 shares of common stock.
Ouvrir le dépôt 0001179110-20-007206 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)40315,26
12 610,4

Calculé : actions × prix par action. Valeur exacte 12610.40.

8 210Indirecte (I) by Caraluna 1 TrustOui
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)85316,9256
26 938,676

Calculé : actions × prix par action. Valeur exacte 26938.6760.

8 125Indirecte (I) By Caraluna 1 TrustOui
F1, F3, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.4100 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)145317,8748
46 091,846

Calculé : actions × prix par action. Valeur exacte 46091.8460.

7 980Indirecte (I) By Caraluna 1 TrustOui
F1, F4, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)240319,7733
76 745,592

Calculé : actions × prix par action. Valeur exacte 76745.5920.

7 740Indirecte (I) By Caraluna 1 TrustOui
F1, F5, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)160320,0188
51 203,008

Calculé : actions × prix par action. Valeur exacte 51203.0080.

7 580Indirecte (I) By Caraluna 1 TrustOui
F1, F6, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.87 to $320.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)40322
12 880

Calculé : actions × prix par action. Valeur exacte 12880.

7 540Indirecte (I) By Caraluna 1 TrustOui
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)40323,0650
12 922,6

Calculé : actions × prix par action. Valeur exacte 12922.6000.

7 500Indirecte (I) By Caraluna 1 TrustOui
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)40315,28
12 611,2

Calculé : actions × prix par action. Valeur exacte 12611.20.

8 210Indirecte (I) By Caraluna 2 TrustOui
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)48317,3253
15 231,6144

Calculé : actions × prix par action. Valeur exacte 15231.6144.

8 162Indirecte (I) By Caraluna 2 TrustOui
F1, F7, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.5200 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)182317,9626
57 869,1932

Calculé : actions × prix par action. Valeur exacte 57869.1932.

7 980Indirecte (I) By Caraluna 2 TrustOui
F1, F8, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)240319,2167
76 612,008

Calculé : actions × prix par action. Valeur exacte 76612.0080.

7 740Indirecte (I) By Caraluna 2 TrustOui
F1, F9, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)120320,0683
38 408,196

Calculé : actions × prix par action. Valeur exacte 38408.1960.

7 620Indirecte (I) By Caraluna 2 TrustOui
F1, F10, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.9450 to $320.2600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)80322,8750
25 830

Calculé : actions × prix par action. Valeur exacte 25830.0000.

7 540Indirecte (I) By Caraluna 2 TrustOui
F1, F11, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.62 to $323.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
11 nov. 2026 Déposé le 13 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)40324,76
12 990,4

Calculé : actions × prix par action. Valeur exacte 12990.40.

7 500Indirecte (I) By Caraluna 2 TrustOui
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Ouvrir le dépôt 0001646649-26-000045 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)15304,5713
4 568,5695

Calculé : actions × prix par action. Valeur exacte 4568.5695.

217 597Directe (D) Oui
F1, F2, F3
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.24 to $304.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F3 Includes 38 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on October 31, 2026
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)51305,7527
15 593,3877

Calculé : actions × prix par action. Valeur exacte 15593.3877.

217 546Directe (D) Oui
F1, F4
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.30 to $306.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)21306,4633
6 435,7293

Calculé : actions × prix par action. Valeur exacte 6435.7293.

217 525Directe (D) Oui
F1, F5
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.39 to $306.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)50308,1980
15 409,9

Calculé : actions × prix par action. Valeur exacte 15409.9000.

217 475Directe (D) Oui
F1, F6
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.70 to $308.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)64309,0817
19 781,2288

Calculé : actions × prix par action. Valeur exacte 19781.2288.

217 411Directe (D) Oui
F1, F7
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.7200 to $309.6450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)110310,1655
34 118,205

Calculé : actions × prix par action. Valeur exacte 34118.2050.

217 301Directe (D) Oui
F1, F8
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.81 to $310.66 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)100311,3116
31 131,16

Calculé : actions × prix par action. Valeur exacte 31131.1600.

217 201Directe (D) Oui
F1, F9
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.99 to $311.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)106312,1965
33 092,829

Calculé : actions × prix par action. Valeur exacte 33092.8290.

217 095Directe (D) Oui
F1, F10
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.00 to $312.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)74313,3168
23 185,4432

Calculé : actions × prix par action. Valeur exacte 23185.4432.

217 021Directe (D) Oui
F1, F11
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.01 to $314.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)108314,7084
33 988,5072

Calculé : actions × prix par action. Valeur exacte 33988.5072.

216 913Directe (D) Oui
F1, F12
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.04 to $315.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)169315,4827
53 316,5763

Calculé : actions × prix par action. Valeur exacte 53316.5763.

216 744Directe (D) Oui
F1, F13
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.0900 to $316.0750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)1 838316,8674
582 402,2812

Calculé : actions × prix par action. Valeur exacte 582402.2812.

214 906Directe (D) Oui
F1, F14
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.24 to $317.14 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)56318,1661
17 817,3016

Calculé : actions × prix par action. Valeur exacte 17817.3016.

214 850Directe (D) Oui
F1, F15
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F15 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.36 to $318.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)105319,2993
33 526,4265

Calculé : actions × prix par action. Valeur exacte 33526.4265.

214 745Directe (D) Oui
F1, F16
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F16 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.67 to $319.66 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)131320,0673
41 928,8163

Calculé : actions × prix par action. Valeur exacte 41928.8163.

214 614Directe (D) Oui
F1, F17
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F17 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.67 to $320.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)51321,1191
16 377,0741

Calculé : actions × prix par action. Valeur exacte 16377.0741.

214 563Directe (D) Oui
F1, F18
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F18 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.77 to $321.63 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)16321,85
5 149,6

Calculé : actions × prix par action. Valeur exacte 5149.60.

214 547Directe (D) Oui
F1
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)40323,8590
12 954,36

Calculé : actions × prix par action. Valeur exacte 12954.3600.

214 507Directe (D) Oui
F1, F19
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F19 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.3800 to $324.3550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
6 nov. 2026 Déposé le 10 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)45325,0509
14 627,2905

Calculé : actions × prix par action. Valeur exacte 14627.2905.

214 462Directe (D) Oui
F1, F20
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F20 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.56 to $325.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0001646649-26-000044 Lu dans le XML du dépôt Contester cette ligne
3 nov. 2026 Déposé le 4 nov. 2026Brophy Michael Burkes Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)470391,49
184 000,3

Calculé : actions × prix par action. Valeur exacte 184000.30.

45 779Directe (D) Oui
F2
  • F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as modified on September 10, 2025.
Ouvrir le dépôt 0001697362-26-000024 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Fesko John Officer: PRESIDENT, CHIEF BUS. OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)7388,2001
2 717,4007

Calculé : actions × prix par action. Valeur exacte 2717.4007.

195 571Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0002010135-26-000028 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Fesko John Officer: PRESIDENT, CHIEF BUS. OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)295400,2942
118 086,789

Calculé : actions × prix par action. Valeur exacte 118086.7890.

195 276Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0002010135-26-000028 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Rabinowitz Matthew Director · Officer: EXECUTIVE CHAIRMAN
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)17388,20
6 599,4

Calculé : actions × prix par action. Valeur exacte 6599.40.

2 117 659Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0001646382-26-000029 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Rabinowitz Matthew Director · Officer: EXECUTIVE CHAIRMAN
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)731400,2942
292 615,0602

Calculé : actions × prix par action. Valeur exacte 292615.0602.

2 116 928Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0001646382-26-000029 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)3388,20
1 164,6

Calculé : actions × prix par action. Valeur exacte 1164.60.

217 683Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0001646649-26-000043 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)109400,2942
43 632,0678

Calculé : actions × prix par action. Valeur exacte 43632.0678.

217 574Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0001646649-26-000043 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Brophy Michael Burkes Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)8388,0301
3 104,2408

Calculé : actions × prix par action. Valeur exacte 3104.2408.

46 566Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs) and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0001697362-26-000024 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Brophy Michael Burkes Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)317400,2942
126 893,2614

Calculé : actions × prix par action. Valeur exacte 126893.2614.

46 249Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs) and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0001697362-26-000024 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026RABINOWITZ DANIEL Officer: SEC. AND CHIEF LEGAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)7388,20
2 717,4

Calculé : actions × prix par action. Valeur exacte 2717.40.

168 214Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0001857843-26-000033 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026RABINOWITZ DANIEL Officer: SEC. AND CHIEF LEGAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)334400,2942
133 698,2628

Calculé : actions × prix par action. Valeur exacte 133698.2628.

167 880Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0001857843-26-000033 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)9388,2001
3 493,8009

Calculé : actions × prix par action. Valeur exacte 3493.8009.

104 733Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0002010019-26-000038 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)410400,2942
164 120,622

Calculé : actions × prix par action. Valeur exacte 164120.6220.

104 323Directe (D) Oui
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Ouvrir le dépôt 0002010019-26-000038 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)200405,2560
81 051,2

Calculé : actions × prix par action. Valeur exacte 81051.2000.

104 123Directe (D) Oui
F2, F3
  • F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
  • F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.8500 to $405.8450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0002010019-26-000038 Lu dans le XML du dépôt Contester cette ligne
2 nov. 2026 Déposé le 4 nov. 2026Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Cédé (D)432406,9398
175 797,9936

Calculé : actions × prix par action. Valeur exacte 175797.9936.

103 691Directe (D) Oui
F2, F4
  • F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
  • F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.4150 to $407.3750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Ouvrir le dépôt 0002010019-26-000038 Lu dans le XML du dépôt Contester cette ligne

Détenteurs institutionnels (formulaire 13F)

Aucune position du formulaire 13F n’est rattachée à cet émetteur dans le magasin. Un détenteur non encore rattaché ou n’ayant pas encore déposé est absent, pas à zéro.

Détenteurs de 5 % (annexes 13D et 13G)

Les annexes déposées au format structuré de la SEC (depuis fin 2024) sont lues ici. Les précédentes sont en texte libre et ne sont pas lues.

Détenteurs de 5 %, événement le plus récent d’abord, tels que déposés
DétenteurPourcentage de la catégorieActions détenuesDate de l’événementFormulaireSource
FMR LLC COMMON STOCK10.515 131 244,7210/30/2026 Déposé le 6 nov. 2026SCHEDULE 13G/AModification 1Ouvrir le dépôt 0000315066-26-002940 Contester cette ligne
Abigail P. Johnson COMMON STOCK10.515 131 244,7210/30/2026 Déposé le 6 nov. 2026SCHEDULE 13G/AModification 1Ouvrir le dépôt 0000315066-26-002940 Contester cette ligne
T. Rowe Price Associates, Inc. COMMON STOCK4.76 786 01709/30/2026 Déposé le 16 nov. 2026SCHEDULE 13G/AModification 5Ouvrir le dépôt 0000080255-26-000696 Contester cette ligne
FMR LLC COMMON STOCK9.513 659 508,2509/30/2026 Déposé le 5 nov. 2026SCHEDULE 13GOuvrir le dépôt 0000315066-26-002810 Contester cette ligne
Abigail P. Johnson COMMON STOCK9.513 659 508,2509/30/2026 Déposé le 5 nov. 2026SCHEDULE 13GOuvrir le dépôt 0000315066-26-002810 Contester cette ligne
T. Rowe Price Associates, Inc. COMMON STOCK6.39 021 82506/30/2026 Déposé le 14 août 2026SCHEDULE 13G/AModification 4Ouvrir le dépôt 0000080255-26-000548 Contester cette ligne
Vanguard Capital Management Common Stock5.087 205 93903/31/2026 Déposé le 30 avr. 2026SCHEDULE 13GOuvrir le dépôt 0002100119-26-000780 Contester cette ligne
The Vanguard Group Common Stock0003/13/2026 Déposé le 27 mars 2026SCHEDULE 13G/AModification 7Ouvrir le dépôt 0000102909-26-001882 Contester cette ligne
T. Rowe Price Associates, Inc. COMMON STOCK7.810 872 70212/31/2025 Déposé le 17 févr. 2026SCHEDULE 13G/AModification 3Ouvrir le dépôt 0000080255-26-000263 Contester cette ligne
JPMORGAN CHASE CO. Common Stock, par value $0.0001 per share9.112 825 64012/31/2025 Déposé le 23 janv. 2026SCHEDULE 13G/AModification 2Ouvrir le dépôt 0000019617-26-000064 Contester cette ligne
T. Rowe Price Associates, Inc. COMMON STOCK8.912 191 81406/30/2025 Déposé le 14 août 2025SCHEDULE 13G/AModification 2Ouvrir le dépôt 0000080255-25-000584 Contester cette ligne
JPMORGAN CHASE CO. Common Stock, par value $0.0001 per share7.710 594 25606/30/2025 Déposé le 22 juil. 2025SCHEDULE 13G/AModification 1Ouvrir le dépôt 0000019617-25-000544 Contester cette ligne

Le pourcentage porte sur la catégorie que nomme le dépôt, tel que l’a déclaré le détenteur. Les membres d’un groupe déclarent chacun les actions du groupe ; les lignes ne s’additionnent donc pas.

Ce qui a été lu

2 212 651 dépôts lus, datés du 14 juin 2004 au 16 nov. 2026 : formulaires 3, 3/A, 4, 4/A, 5, 5/A.

Certaines années peuvent être incomplètes tant que l’archive est en cours de lecture. Une année avec peu de dépôts ici n’affirme pas qu’il y en a eu peu.

Dépôts lus, par année de dépôt
Année de dépôtDépôts lus
20151
2016204 322
2017202 494
2018202 048
2019193 638
2020144 184
2021224 474
2022130 393
2023199 811
2024209 823
2025235 520
2026260 165

Les dépôts antérieurs à l’obligation du XML par la SEC sont listés, non extraits.

Retour à Natera, Inc.